Preventing colorectal cancer
Authors:
MUDr. CSc. Tomislav Švestka; doc. MUDr. CSc. Tomáš Krechler
Authors place of work:
IV. interní klinika 1. LF UK a VFN : U Nemocnice, 128 08 Praha
2
Published in the journal:
Čas. Lék. čes. 2016; 155: 81-83
Category:
Review Articles
Summary
Colorectal cancer is one the most frequently diagnosed cancer at the presence. The mortality can be reduced by early investigations. Screening tests are able to detect both early adenomatous polyps and cancers soon (immunochemical tests, colonoscopy and other methods − virtual colonoscopy etc.).
Keywords:
colorectal cancer, screening tests, diagnostics
Zdroje
1. Dušek L, Mužík T, Pavlík T et al. Epidemiologie zhoubných nádorů trávicího traktu v České republice - současný stav a predikce. Gastroent Hepatol 2012; 66: 331−339.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225−249.
3. Whitlock EP, Lin JS, Liles E et al. Screening for colorectal cancer: a targeted, updated systematic review for U.S. Preventive Services Task Force. Ann Intern Med 2008; 149: 638−658.
4. Treyzon L, Ohnany G, Herber D. Colon cancer. In: Heber D et al. Nutritional Oncology (2nd ed.). San Diego: Academic Press, Elsevier 2006, p. 423−435.
5. Blackburn G, Waltman B. Obesity and insulin resistance. In: McTiernan A. Cancer Prevention and Management through Excercise and Weight Control. Nutrition and Disease Prevention (1st ed.). New York: CRC Press 2005, p. 301−316.
6. Fearon ER, Sommefeld GT. Molecular biology of colorectal cancer. In: Devita VT jr., Lawrence TS, Rosenberg SA. Principles and Practice of Oncology (8th ed.). Philadelphia: Wolters Kluwer, Lippincott Williams and Wilkins 2008, p. 1218−1232.
7. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 2007; 57: 90−104.
8. Giouleme O, Diamantidis MD, Katsaros MG. Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanism. World J Gastroenterol 2011; 17: 444−448.
9. Chan A, Giovannucci E. Primary prevention of colorectal cancer. Gastroenterology 2010; 138: 2169−2180.
10. Collins JF, Lieberman DA, Durbin TE, Weiss DG. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med 2005; 142: 81−85.
11. Sox HC. Office-based testing for fecal occult blood: do only in case of emergency. Ann Intern Med 2005; 142: 146−148.
12. Zavoral M, Závada F. Screeningová kolonoskopie − nové horizonty, nová zodpovědnost. Čes a Slov Gastroent a Hepatol 2008; 62: 61−67.
13. Holl L, van Leerdam ME, van Ballegooijen M et al. Screening for colorectal cancer, randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoideoscopy. Gut 2010; 59: 62−68.
14. Zavoral M, Grega T, Vojtěchová G, Suchánek Š. Screening kolorektálního karcinomu. Postgrad med 2014; 16: 771−780.
15. Zavoral M, Suchánek Š, Grega T et al. 15 let programu „Screening kolorektálního karcinomu“ v České republice-úskalí a úspěchy. In: Aktuální gastroenterologie XXX. 2015; 8−9.
16. Zavoral M, Závada F. Screeningová kolonoskopie − nové horizonty, nová zodpovědnost. Čes Slov Gastroenterol Hepatol 2008; 62: 61−67.
17. Nosek V. Kolorektální screening a projekt adresného zvaní − zpětná vazba. Gastroent Hepatol 2014; 68: 255.
18. Zavoral M, Špičák J, Suchánek Š. Vyjádření ke zpětné vazbě na program adresného zvaní ke kolorektálnímu screeningu. Gastroent Hepatol 2014; 68: 256−257.
19. Ozsunar Y, Coscun G, Delibas N et al. Diagnostic accuracy and tolerability of contrast enhanced CT colonoscopy in symptomatic patients with increased risk for colorectal cancer. Eur J Radiol 2008; 5: 1−6.
20. Zavoral M, Májek O, Tachecí I et al. Porovnání účinnosti kolonické kapslové endoskopie a kolonoskopie v detekci polypů a karcinomů tlustého střeva a konečníku − multicentrická, prospektivní, cross-over studie. Gastroent Hepatol 2014; 68: 218−232.
21. Špičák J, Kovářová JT. Pokroky ve screeningu kolorektálního karcinomu. Postgrad Med 2012; 14: 1−9.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Evaluation and treatment of portal hypertension
- Refeeding syndrome
- Desaturases of fatty acids (FADS) and their physiological and clinical implication
- Czech section of International College of Surgeons and Jubilee surgical world congress